, Tracking Stock Market Picks
Enter Symbol:
Gentium Spa (GENTY) [hlAlert]

up 135.71 %

Gentium Spa (GENT) rated Buy

Posted on: Friday,  Sep 21, 2007  9:25 AM ET by Broadpoint Capital

Broadpoint Capital rated Buy Gentium Spa (OTCBB: GENTY) on 09/21/2007, when the stock price was $23.80. Since
then, Gentium Spa has gained 135.71% as of 04/11/2014's recent price of $56.10.
If you would have followed this Broadpoint Capital's recommendation on GENTY, you would have gained 135.71% of your investment in 2394 days.

Gentium S.p.A. is a biopharmaceutical company focused on the development and manufacture of defibrotide, a deoxyribonucleic acid (DNA) based drug derived from pig intestines, to treat and prevent a disease called hepatic veno-occlusive disease (VOD), a condition in which some of the veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation treatments that are given prior to stem cell transplantation. The Company is concluding a Phase III clinical trial of defibrotide to treat severe VOD in the United States, Canada and Israel. The Company is also conducting a Phase II/III clinical trial of defibrotide in Europe to prevent VOD in children. In addition to defibrotide, the Company sells urokinase, calcium heparin, sodium heparin and sulglicotide, which are active pharmaceutical ingredients used to make other drugs.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/25/2008 8:25 AM Buy
10.67 25.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2007 9:25 AM Buy
23.80 34.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy